Clinical Trial Applications for Biologics and Radiopharmaceuticals

Clinical Trial Applications for pharmaceutical (Schedule F), radiopharmaceutical (Schedule C) and biological (Schedule D) drugs are all regulated under Part C, Division 5 of the Food and Drug Regulations, and therefore all must adhere to the same regulatory requirements. However, biological drugs carry additional risks associated with complexity and variability in manufacturing.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Demandes d'essais cliniques pour les produits biologiques et radiopharmaceutiques
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Demandes d'essais cliniques", "CTA pour les produits biologiques", "CTA radiopharmaceutiques", "médicaments biologiques"], "en": ["Clinical Trial Applications", "CTA for Biologics", "CTA Radiopharmaceuticals", "biological drugs"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source